Boothbay Fund Management’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-52,100	Closed	-$4.41M	–	1416
2024 Q4	$4.41M	Buy	+52,100	New	+$4.79M	0.13%	263
2023 Q3	–	Sell	-36,900	Closed	-$2.65M	–	1731
2023 Q2	$2.65M	Buy	36,900 +5,600	+18%	+$413K	0.08%	444
2023 Q1	$1.93M	Sell	31,300 -111,200	-78%	-$7.31M	0.05%	682
2022 Q4	$11M	Buy	+142,500	New	+$8.52M	0.33%	54
2022 Q3	–	Sell	-46,800	Closed	-$1.79M	–	2243
2022 Q2	$1.79M	Buy	+46,800	New	+$1.48M	0.06%	586
2021 Q4	–	Sell	-61,000	Closed	-$2.01M	–	1872
2021 Q3	$2.01M	Buy	+61,000	New	+$2.38M	0.08%	443
2020 Q2	–	Sell	-362	Closed	-$2.13M	–	972
2020 Q1	$2.13M	Buy	+362	New	+$29.5K	0.22%	150
2019 Q4	–	Sell	-525	Closed	-$1.06M	–	856
2019 Q3	$1.06M	Buy	+525	New	+$13.5K	0.13%	292